Assignors: EBERT, PETER S., HALLER, STEPHAN, VOGLER, HARTMUT K., LIN, TAO, MO, BRIAN S., SWAN, RICHARD J., WENG, JIE Application granted granted Critical Publication of US7737857B2 publication Critical patent/US7737857B2/en Assigned to SAP SE reassignment SAP SE CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Priority to US34767202P priority Critical Priority to US35343902P priority Priority to US35319802P priority Priority to US10/136,852 priority patent/US7233958B2/en Priority to US10/137,207 priority patent/US7151453B2/en Priority to US10/210,859 priority patent/US7290708B2/en Priority to US10/232,764 priority patent/US6901304B2/en Priority to US10/255,115 priority patent/US20030132855A1/en Priority to US10/285,381 priority patent/US6843415B2/en Priority to US10/340,208 priority patent/US7969306B2/en Application filed by SAP SE filed Critical SAP SE Priority to US12/333,808 priority patent/US7737857B2/en Publication of US20090146832A1 publication Critical patent/US20090146832A1/en Assigned to SAP AKTIENGESELLSCHAFT reassignment SAP AKTIENGESELLSCHAFT ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Original Assignee SAP SE Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.) Mo Stephan Haller Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.) Granted Application number US12/333,808 Other versions US7737857B2
#IDIVE SEATTLE PDF#
Google Patents Context-aware and real-time item tracking system architecture and scenariosĭownload PDF Info Publication number US20090146832A1 US20090146832A1 US12/333,808 US33380808A US2009146832A1 US 20090146832 A1 US20090146832 A1 US 20090146832A1 US 33380808 A US33380808 A US 33380808A US 2009146832 A1 US2009146832 A1 US 2009146832A1 Authority US United States Prior art keywords item information model items parent Prior art date Legal status (The legal status is an assumption and is not a legal conclusion.
Google Patents US20090146832A1 - Context-aware and real-time item tracking system architecture and scenarios
#IDIVE SEATTLE TRIAL#
The trial is expected to begin in the third quarter, the company said.US20090146832A1 - Context-aware and real-time item tracking system architecture and scenarios In June, Sonoma received Food and Drug Administration permission to begin human testing of a fusion protein drug candidate that’s designed to be used as a “preconditioning” regimen ahead of Treg cell treatment. The company signed a “long-term” lease for the site, which is located on the Seattle waterfront. Sonoma said its facility would include capabilities for cell selection, genetic modification and automated manufacturing. “Seattle has an established legacy of delivering many firsts in the cell therapy field for cancer, and we are building upon those insights to advance our pipeline of engineered Treg therapies for autoimmune and inflammatory diseases,” said Bluestone, in a statement. Sonoma is based in South San Francisco, but it chose Seattle for its new manufacturing center in part because of the area’s history with cell therapy. It’s one of a handful of startups exploring Tregs, which have also begun to draw attention from larger pharmaceutical companies. Launched by well-known immunology Jeffrey Bluestone, the biotech has raised more than $335 million to date.
0 kommentar(er)
